Yahoo
Shenzhen - Delayed Quote CNY

Xi'an International Medical Investment Company Limited (000516.SZ)

4.5000 +0.1000 (+2.27%)
At close: 3:05:00 PM GMT+8
Chart Range Bar
Loading chart for 000516.SZ
  • Previous Close 4.4000
  • Open 4.3600
  • Bid 4.4900 x --
  • Ask 4.5000 x --
  • Day's Range 4.4000 - 4.5000
  • 52 Week Range 3.8200 - 6.1900
  • Volume 31,132,335
  • Avg. Volume 21,534,465
  • Market Cap (intraday) 10.075B
  • Beta (5Y Monthly) 0.13
  • PE Ratio (TTM) --
  • EPS (TTM) -0.0400
  • Earnings Date --
  • Forward Dividend & Yield -- (0.00%)
  • 1y Target Est 5.70
  • Moby Rating Neutral

Xi'an International Medical Investment Company Limited provides healthcare services in China. It operates hospitals and medical centers. The company also engages in insurance broking, E-commerce, health and asset management, tourism, professional design, technological development, food and beverages, and pharmaceutical production business. The company was formerly known as Xi'an Kaiyuan Investment Group Co., Ltd. and changed its name to Xi'an International Medical Investment Company Limited in January 2015. Xi'an International Medical Investment Company Limited was founded in 1986 and is based in Xi'an, China.

www.000516.cn

8,055

Full Time Employees

December 31

Fiscal Year Ends

Healthcare

Sector

Recent News

View More

Performance Overview

Trailing total returns as of 11/2/2026, which may include dividends or other distributions. Benchmark is SSE Composite Index (000001.SS) .

YTD Return

000516.SZ
4.90%
SSE Composite Index (000001.SS)
8.34%

1-Year Return

000516.SZ
6.25%
SSE Composite Index (000001.SS)
8.01%

3-Year Return

000516.SZ
51.35%
SSE Composite Index (000001.SS)
20.89%

5-Year Return

000516.SZ
61.77%
SSE Composite Index (000001.SS)
3.78%

Earnings Trends

View More

Earnings Per Share

Revenue vs. Earnings

Annual
Quarterly
Annual
Quarterly
Q1 FY24
Revenue 1.17B
Earnings -104.91M
Profit Margin -8.94%

Q1

FY24

0
500M
1B
-8.9%

Analyst Insights

View More

Analyst Price Targets

5.70
5.70 Average
4.5000 Current
5.70 High

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell

Statistics

View More

Valuation Measures

Annual
  • Market Cap

  • Enterprise Value

  • Trailing P/E

  • Forward P/E

  • PEG Ratio (current)

  • Price/Sales (ttm)

  • Price/Book (mrq)

  • Enterprise Value/Revenue

  • Enterprise Value/EBITDA

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -2.16%

  • Return on Assets (ttm)

    -0.47%

  • Return on Equity (ttm)

    -6.55%

  • Revenue (ttm)

    4.16B

  • Net Income Avi to Common (ttm)

    -89.8M

  • Diluted EPS (ttm)

    -0.0400

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    379.74M

  • Total Debt/Equity (mrq)

    144.14%

  • Levered Free Cash Flow (ttm)

    403.25M

Company Insights

Research Reports

View More

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: